Current treatment of Helicobacter pylori infection and peptic ulcer disease.

Current treatment of Helicobacter pylori infection and peptic ulcer disease. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Current treatment of Helicobacter pylori infection and peptic ulcer disease. Abstract Text:

G Cleghorn,

Since the initial report by Warren and Marshall in 1984, Helicobacter pylori has assumed an increasingly important role in the pathogenesis of peptic ulcer disease and gastric carcinoma in all ages. A recent National Institutes of Health Consensus Development conference acknowledges the relationship between H. pylori infection and peptic ulcer disease and recommends that the medical community treat H. pylori infection in all patients with Helicobacter pylori and peptic ulcer. Although the same organism, the response to Helicobacter pylori infection in childhood differs somewhat from that seen in adults. The paediatric patient mounts a different inflammatory response, has different macroscopic appearances and has a markedly diminished peptic ulcer disease frequency compared with their adult counterparts. The appearances of antral nodularity appear to be characteristic of Helicobacter pylori infections. The appearances, however, are unrelated to symptoms and the underlying cause for this nodularity remains obscure. Younger children with peptic ulcer diseases are more likely to be Helicobacter pylori negative. This may suggest an increased susceptibility to gastric acid or possibly a very transient Helicobacter pylori infection rather than the well described lifelong infection without treatment. It is well known that the epidemiology of Helicobacter pylori would suggest that the incidence of infection increases with age. There is also geographical variations with the incidence being higher in countries of a third world background. These epidemiological observations fly in the face of all other infections where the major period of acquisition is in childhood. There has been recent evidence to suggest that in fact the incidence in childhood is decreasing in developed countries which could support the observation that there is a decreasing positive serology with successive decades in some countries. It is felt that the most likely mode of transmission to Helicobacter pylori is faecal to oral or oral to oral route. These are similar modes of transmission to Hepatitis A infections. It is obvious that most infections in childhood remain asymptomatic. It is also clear that there is no relationship between chronic recurrent abdominal pain of childhood syndrome and the presence of Helicobacter pylori infections. It remains to be seen as to who should be treated, what with and when. All of these issues will be discussed in the paper.

Current treatment of Helicobacter pylori infection and peptic ulcer disease. Publishing Authors By Initials

G Cleghorn,

For similar digestive system diseases: gastrointestinal diseases: intestinal diseases: duodenal diseases: peptic ulcer research abstracts see: digestive system diseases: gastrointestinal diseases: intestinal diseases: duodenal diseases: peptic ulcer research

PUBMED ID PMID:

MEDLINE DATE:

Current treatment of Helicobacter pylori infection and peptic ulcer disease. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Zhonghua Minguo xiao er ke yi xue hui za zhi [Jour

VOLUME: 38

Page Numbers: 178-82

Journal Abbreviation:

ISSN: 0001-6578

DAY: 12

MONTH: 02

YEAR: 2008

Current treatment of Helicobacter pylori infection and peptic ulcer disease. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 16210470

Current treatment of Helicobacter pylori infection and peptic ulcer disease. Keywords Mesh Terms:

KEYWORDS: Peptic Ulcer

MESH TERMS: drug therapy

Chemical & Substance for Abstract: Current treatment of Helicobacter pylori infection and peptic ulcer disease. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Current treatment of Helicobacter pylori infection and peptic ulcer disease.

AFFILIATION: University of Queensland, Australia.

Country: TAIWAN

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Zhonghua Min Guo Xiao Er Ke Yi

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Current treatment of Helicobacter pylori infection and peptic ulcer disease Related Publications

• Adrenal cortical insufficiency: psychological and neurological observations.
• Clotting factor concentrates.
• Cryoprecipitate and the plastic blood-bag system: provision of adequate replacement therapy for routine treatment of haemophilia.
• Current treatment of Helicobacter pylori infection and peptic ulcer disease.
• Developments in psychoneuroendocrinology: a tribute to the research of Robert A Cleghorn, 1904-1995.
• Hip arthroplasty in a haemophiliac and subsequent prophylactic therapy with cryoprecipitate.
• INTERFERON.
• Implications of positron emission tomography research for the investigation of the actions of antipsychotic drugs.
• MALIGNANT DISEASE IN CHILDREN.
• Psychological aspects of surgical mutilation.
• Psychosomatic medicine and altered autonomic and humoral function.
• SERUM-ALKALINE-PHOSPHATASE AND THE ABO BLOOD-GROUPS.
• SUBDURAL INTRACRANIAL EMPYEMA.
• The interaction of physiological and psychological processes in adaptation.
• [Retroviruses in the Caribbean]